Showing results (81-90 of 729) with videos related to
Sort By:
Pageof 73
American Heart Journal|November 5, 2003
Optimizing glycoprotein IIb/IIIa receptor antagonist use for the non-ST-segment elevation acute coronary syndromes: risk stratification and therapeutic interventionJames L Januzzi, Christopher P Cannon, Pierre Theroux, et al.Archives of Pathology & Laboratory Medicine|November 29, 2002
Positive predictive value of a point-of-care testing strategy on first-draw specimens for the emergency department-based detection of acute coronary syndromesAlexander Kratz, James L Januzzi, Kent B Lewandrowski, et al.The American Journal of Cardiology|February 22, 2008
Importance and interpretation of intermediate (gray zone) amino-terminal pro-B-type natriuretic peptide concentrationsRoland R J van Kimmenade, Yigal M Pinto, James L JanuzziThe American Journal of Cardiology|February 22, 2008
Amino-terminal pro-B-type natriuretic peptide testing and prognosis in patients with acute dyspnea, including those with acute heart failureAaron L Baggish, Roland R J van Kimmenade, James L JanuzziCardiology and Therapy|July 12, 2026
Defining Heart Failure Endpoint in ATTR Amyloidosis Clinical Trials: Time for an Update?Diona Gjermeni, Kevin M Alexander, James L Januzzi, et al.Journal of the American College of Cardiology|March 21, 2020
Inflammation in Heart Failure: JACC State-of-the-Art ReviewSean P Murphy, Rahul Kakkar, Cian P McCarthy, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|April 5, 2008
Independent and incremental prognostic value of multimarker testing in acute dyspnea: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) studyShafiq U Rehman, Abelardo Martinez-Rumayor, Thomas Mueller, et al.The American Journal of Cardiology|February 22, 2008
The differential diagnosis of an elevated amino-terminal pro-B-type natriuretic peptide levelAaron L Baggish, Roland R J van Kimmenade, James L JanuzziClinical Science (London, England : 1979)|November 15, 2007
Erythropoietin in cardiovascular diseases: exploring new avenuesPeter van der Meer, Dirk J van Veldhuisen, James L JanuzziClinical Chemistry|November 21, 2013
Biomarkers in ACS and heart failure: should men and women be interpreted differently?Shweta R Motiwala, Amy Sarma, James L Januzzi, et al.Pageof 73